perylene and aminolevulinic acid
perylene has been researched along with aminolevulinic acid in 15 studies
Research
Studies (15)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Pytel, A; Schmeller, N | 1 |
| Bezdetnaya, L; D'Hallewin, MA; Guillemin, F | 1 |
| Höpfner, M; Kashtan, H; Lenz, M; Maaser, K; Riecken, EO; Scherübl, H; Sutter, AP; Theiss, A; von Lampe, B; Zeitz, M | 1 |
| Hao, GY; Zhang, YH | 1 |
| Jain, S; Kockelbergh, RC | 1 |
| Marberger, M; Schmidbauer, J | 1 |
| Boiy, A; de Witte, PA; Roelandts, R; van den Oord, J | 1 |
| Fedier, A; Kurmanaviciene, A; Minder, EI; Roos, M; Roth, M; Schneider-Yin, X; Walt, H | 1 |
| de Witte, PA; Hettinger, K; Van Cleynenbreugel, B; Van Poppel, H; Vandepitte, J | 1 |
| Berlanda, J; Engelhardt, V; Kiesslich, T; Krammer, B; Plaetzer, K | 1 |
| Boiy, A; de Witte, PA; Roelandts, R | 1 |
| Dietz, K; Noell, S; Ritz, R; Roser, F; Scheidle, C; Schenk, M; Strauss, WS | 1 |
| Breit, P; Kratky, KW; Loew, HG; Penjweini, R | 1 |
| Adelzadeh, L; Choi, YM; Wu, JJ | 1 |
| Abrahamse, H; Kruger, CA; Naidoo, C | 1 |
Reviews
6 review(s) available for perylene and aminolevulinic acid
| Article | Year |
|---|---|
Fluorescence detection of bladder cancer: a review.
Topics: Administration, Intravesical; Aminolevulinic Acid; Anthracenes; Carcinoma in Situ; Cystoscopy; Dihematoporphyrin Ether; Fluorescence; Humans; Perylene; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2002 |
[Fluorescence technique on diagnosis of urinary bladder carcinoma].
Topics: Aminolevulinic Acid; Anthracenes; Fluorescence; Humans; Perylene; Urinary Bladder Neoplasms | 2003 |
The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer.
Topics: Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Carcinoma, Transitional Cell; Cystoscopy; Disease Progression; Hematuria; Humans; Perylene; Photochemotherapy; Photosensitizing Agents; Radiation-Sensitizing Agents; Urinary Bladder Neoplasms | 2005 |
Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
Topics: Aminolevulinic Acid; Anthracenes; Carcinoma in Situ; Cystoscopy; Fluorescence; Fluorescent Dyes; Humans; Perylene; Practice Guidelines as Topic; Predictive Value of Tests; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2007 |
Photodynamic therapy for psoriasis.
Topics: Aminolevulinic Acid; Anthracenes; Humans; Perylene; Photochemotherapy; Photosensitizing Agents; Porphyrins; Psoriasis; Verteporfin | 2015 |
Simultaneous Photodiagnosis and Photodynamic Treatment of Metastatic Melanoma.
Topics: Aminolevulinic Acid; Anthracenes; Biopsy, Fine-Needle; Drug Carriers; Early Diagnosis; Humans; Indoles; Isoindoles; Light; Lymphatic Metastasis; Melanoma; Molecular Imaging; Nanoparticles; Perylene; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2019 |
Other Studies
9 other study(ies) available for perylene and aminolevulinic acid
| Article | Year |
|---|---|
New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Anthracenes; Carcinoma in Situ; Cystitis; Cytophotometry; Humans; Microscopy, Fluorescence; Middle Aged; Neoplasm Staging; Perylene; Photosensitizing Agents; Pilot Projects; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2002 |
Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Perylene; Photochemotherapy; Photosensitizing Agents; Time Factors; Tumor Cells, Cultured | 2003 |
Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Anthracenes; Dermatitis, Phototoxic; Female; Male; Mice; Mice, Inbred BALB C; Perylene; Photosensitizing Agents; Radiation-Sensitizing Agents; Skin; Time Factors | 2008 |
Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light.
Topics: Aminolevulinic Acid; Anthracenes; Apoptosis; Cell Line, Tumor; Drug Synergism; Endometrial Neoplasms; Female; Humans; Light; Perylene; Photosensitizing Agents; Protoporphyrins | 2009 |
Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder.
Topics: Aminolevulinic Acid; Animals; Anthracenes; Antineoplastic Agents; Female; Fluorescence; Perylene; Photochemotherapy; Povidone; Protoporphyrins; Rats; Rats, Inbred F344; Solubility; Tissue Distribution; Urinary Bladder Neoplasms | 2011 |
Comparative in vitro study on the characteristics of different photosensitizers employed in PDT.
Topics: Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dihematoporphyrin Ether; Humans; Indoles; Mesoporphyrins; Organometallic Compounds; Perylene; Photochemotherapy; Photosensitizing Agents | 2010 |
Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Anthracenes; Antineoplastic Agents; Disease Models, Animal; Female; Keratosis, Actinic; Mice; Mice, Hairless; Microscopy, Fluorescence; Perylene; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Ultraviolet Rays | 2011 |
In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.
Topics: Aminolevulinic Acid; Anthracenes; Cell Line, Tumor; Cerebellar Neoplasms; Humans; Medulloblastoma; Microscopy, Fluorescence; Perylene; Photochemotherapy; Photosensitizing Agents; Protoporphyrins | 2012 |
Optimizing the antitumor selectivity of PVP-Hypericin re A549 cancer cells and HLF normal cells through pulsed blue light.
Topics: Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Color; Dose-Response Relationship, Radiation; Drug Carriers; Humans; Lung Neoplasms; Perylene; Photochemotherapy; Photosensitizing Agents; Povidone; Sensitivity and Specificity; Treatment Outcome | 2013 |